⌘K

Home/Filings/4/0001593968-24-001472

4//SEC Filing

Casey Mark J 4

Accession 0001593968-24-001472

CIK 0001000694other

View on SEC.gov Company Profile

Filed

Dec 12, 7:00 PM ET

Accepted

Dec 13, 5:24 PM ET

Size

8.2 KB

Accession

0001593968-24-001472

Insider Transaction Report

Form 4

Period: 2024-12-11

NOVAVAX INCNVAX

EVP, Chief Legal Officer

Transactions

Exercise/Conversion
Common Stock
2024-12-11+41,900→ 41,900 total
Exercise/Conversion
Restricted Stock Units
2024-12-11−41,900→ 83,798 total
Exercise: $0.00Exp: 2033-12-11→ Common Stock (41,900 underlying)
Tax Payment
Common Stock
2024-12-11$8.82/sh−12,713$112,129→ 29,187 total

Footnotes (1)

[F1]One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date.

Documents

1 file

4
primary_01.xmlPrimary
PRIMARY DOCUMENT

Issuer

NOVAVAX INC

CIK 0001000694

Entity typeother

Related Parties

1

filerCIK 0001415297

Filing Metadata

Form type: 4
Filed: Dec 12, 7:00 PM ET
Accepted: Dec 13, 5:24 PM ET
Size: 8.2 KB

View on SEC.gov